Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Last Updated: January 27, 2022

DrugPatentWatch Database Preview

Actavis Labs Fl Inc Company Profile

Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for ACTAVIS LABS FL INC, and what generic and branded alternatives to ACTAVIS LABS FL INC drugs are available?

ACTAVIS LABS FL INC has sixty-three approved drugs.

There are five tentative approvals on ACTAVIS LABS FL INC drugs.

Summary for Actavis Labs Fl Inc

US Patents:	0
Tradenames:	52
Ingredients:	50
NDAs:	63

Drugs and US Patents for Actavis Labs Fl Inc

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try it Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Actavis Labs Fl Inc	FLUTAMIDE	flutamide	CAPSULE;ORAL	075820-001	Sep 18, 2001		DISCN	No	No		⤷ Try it Free				⤷ Try it Free
Actavis Labs Fl Inc	DILTIAZEM HYDROCHLORIDE	diltiazem hydrochloride	TABLET, EXTENDED RELEASE;ORAL	077686-003	Mar 15, 2010	AB	RX	No	No		⤷ Try it Free				⤷ Try it Free
Actavis Labs Fl Inc	DESMOPRESSIN ACETATE	desmopressin acetate	TABLET;ORAL	076470-002	Jul 1, 2005	AB	RX	No	No		⤷ Try it Free				⤷ Try it Free
Actavis Labs Fl Inc	MIRTAZAPINE	mirtazapine	TABLET;ORAL	076336-002	Jun 20, 2003		DISCN	No	No		⤷ Try it Free				⤷ Try it Free
Actavis Labs Fl Inc	GLIMEPIRIDE	glimepiride	TABLET;ORAL	076995-003	Apr 27, 2010		DISCN	No	No		⤷ Try it Free				⤷ Try it Free
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Paragraph IV (Patent) Challenges for ACTAVIS LABS FL INC drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Delayed-release Tablets	20 mg	➤ Subscribe	2015-06-03

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter

McKesson

McKinsey

Medtronic

Boehringer Ingelheim

Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.